“The da Vinci 5 system is the next evolution of robotic surgery,” says Dr. Jaschar Shakuri-Rad. #urology #urologist

Watch now: urologytimes.com/view/dr-shakur…

Dr. Shawn H. Marhamati highlights the data and experiences that supported a trial of Aquablation in an ASC setting. Shawn H Marhamati, MD Potomac Urology #BPH #urologist

Watch now: urologytimes.com/view/dr-marham…

A phase 1/2 trial of ONCT-534 in mCRPC continues to progress with the dosing of the first patient in cohort 4 of the study, assessing the therapy at 300 mg. #pcsm #prostatecancer #urology

Read more: urologytimes.com/view/trial-of-…

Dr. Todd M. Morgan discusses the evolving field of salvage therapy in prostate cancer. Todd 〽️ Morgan, MD Michigan Urology #pcsm #urology #urologist

Watch now: urologytimes.com/view/dr-morgan…

Updated data from the phase 3 KEYNOTE-564 trial have been published in the NEJM, showing that adjuvant pembrolizumab extended overall survival vs placebo in patients with ccRCC. Toni Choueiri, MD #kcsm #urology

Read more: urologytimes.com/view/updated-d…

Dr. Keyan Salari discusses how the integration of family history and germline genetics is important in defining the prognosis of patients with prostate cancer. Keyan Salari MGH Urology #pcsm #urology #urologist

Watch now: urologytimes.com/view/integrati…

An 18-gene urine test demonstrated higher diagnostic accuracy for high-grade prostate cancer than existing biomarker tests, suggesting that the urinary panel may help avoid unnecessary biopsies. #pcsm #cancerresearch Michigan Urology

Read more: urologytimes.com/view/18-gene-u…

Dr. Colin Goudelocke discusses data on stand-up urgency in patients with overactive bladder. #OAB #urology Colin Goudelocke

Read here: urologytimes.com/view/dr-goudel…

Check out the first of a three part video series discussing our launch of Ambulatory Surgery Center Aquablation as part of a pilot trial with PROCEPT BioRobotics

Potomac Urology

#bph #aquablation

'We can also look at the timing of exposure to urology. Does early exposure spark interest in urology, or does delayed introduction to the field hinder the consideration of the specialty?' says Ashley Appleton on future work in urology. UCLA Urology
urologytimes.com/view/future-wo…

The first patient has been treated in a phase 1 study of a delta gamma CAR T-cell therapy for patients with bone metastatic prostate cancer. Moffitt Cancer Center #pcsm #urology #cancerresearch

Read more: urologytimes.com/view/study-lau…

Dr. Scott Morgan discusses questions that arise from a study of prostate radiotherapy. #pcsm #prostatecancer #urology

Watch now: urologytimes.com/view/expert-di…

Check out Urology Times' latest video with Dr. Daniel J. Heidenberg from Mayo Clinic in Phoenix! Discover how findings from the recent Urology paper could impact clinical practice. Don't miss this insightful discussion! ow.ly/F8hj50Rh4X2

In Urology Times: The first patient has been dosed in a phase 1 trial exploring the small activating RNA therapy RAG-01 in patients with BCG-unresponsive NMIBC. Click here to read the article: urologytimes.com/view/novel-sma…

“These findings suggest that guideline recommended treatment intensification remains low for patients with mCSPC in both Medicare and the Veterans Health Administration, but especially for Black patients,” says Dr. Dan George. Duke Urology #pcsm
urologytimes.com/view/study-fin…

'We are very excited at Potomac Urology to be the first center in the United States, and just the second center internationally, to offer ambulatory surgery center Aquablation as part of a pilot trial,' says Dr. Marhamati. Shawn H Marhamati, MD Potomac Urology urologytimes.com/view/dr-marham…

“In the future, this imaging technique can help to streamline the drug development process, driving conviction in the agents we bring to larger scale trials,' says Dr. Stephen Rose on 212Pb SPECT/CT imaging. #pcsm #prostatecancer #urology

Read more: urologytimes.com/view/212pb-spe…

Dr. Todd M. Morgan discusses the inclusion of PSMA-PET imaging in the guideline on salvage therapy for prostate cancer. Todd 〽️ Morgan, MD Michigan Urology #pcsm #urology #oncology

Watch now: urologytimes.com/view/prostate-…

Let's dive into cystoscope preferences and practices! Your voice matters in our quick survey developed with Urology Times®. Share your insights now: ow.ly/e10c50Rh3Zj
#Cystoscope #Urology

Dr. Caroline Foxton discusses findings of cobimetinib in combination with 177Lu-rhPSMA-10.1 for prostate cancer. #pcsm #cancerresearch #urology

Read here: urologytimes.com/view/dr-foxton…